Enhabit, Inc. (EHAB)
| Market Cap | 697.44M |
| Revenue (ttm) | 1.06B |
| Net Income (ttm) | -4.60M |
| Shares Out | 50.72M |
| EPS (ttm) | -0.09 |
| PE Ratio | n/a |
| Forward PE | 22.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 586,782 |
| Open | 13.78 |
| Previous Close | 13.74 |
| Day's Range | 13.74 - 13.78 |
| 52-Week Range | 6.47 - 14.22 |
| Beta | 1.09 |
| Analysts | Hold |
| Price Target | 13.84 (+0.65%) |
| Earnings Date | May 6, 2026 |
About EHAB
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s ... [Read more]
Financial Performance
In 2025, Enhabit's revenue was $1.06 billion, an increase of 2.44% compared to the previous year's $1.03 billion. Losses were -$4.60 million, -97.06% less than in 2024.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for EHAB stock is "Hold." The 12-month stock price target is $13.84, which is an increase of 0.65% from the latest price.
News
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders...
Enhabit Reports Fourth Quarter 2025 Financial Results
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth q...
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Enhabit, Inc. (EHAB)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("En...
Enhabit to be Acquired by Kinderhook Industries
DALLAS & NEW YORK--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinder...
Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year en...
Enhabit and Encompass Health Collect $43.1 Million from Individual Defendants in Delaware Fiduciary Breach Case
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) announced today that, along with Encompass Health Corporation (NYSE: EHC), they have collected $43.1 million in full satisfaction of their claims fo...
Enhabit Transcript: Bank of America Home Care Conference
Final home health rate cuts were less severe than expected, supporting profitability and investment plans for 2026. Strategic focus includes disciplined M&A, payer innovation, and operational efficiency, with mid- to high-single digit growth targeted for both home health and hospice.
Enhabit Announces Participation in Bank of America Home Care Conference 2025
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Bank of America Home Care Conference 2025. Enhabit's ...
Enhabit Transcript: UBS Global Healthcare Conference 2025
Hospice outperformed expectations, while home health growth and margin depend on the final CMS rule. Operational pilots and payer strategies are offsetting regulatory risks, and deleveraging has improved financial flexibility. Litigation remains ongoing.
Enhabit Earnings Call Transcript: Q3 2025
Q3 saw strong revenue and EBITDA growth, led by record hospice performance and improved home health metrics. Guidance for full-year revenue, EBITDA, and free cash flow was raised, while leverage and costs improved. Strategic initiatives are in place to address upcoming CMS rate changes.
Enhabit Reports Third Quarter 2025 Financial Results
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025. “Our third qu...
Enhabit Announces Participation in UBS Global Healthcare Conference 2025
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the UBS Global Healthcare Conference 2025. Enhabit's Pres...
Enhabit Home Health & Hospice Announces Date of 2025 Third Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the third quarter ended Sept. 30, 202...
Enhabit Transcript: Jefferies 2025 Healthcare Services Conference
Growth in home health and hospice is driven by payer strategy, operational pilots, and improved contracting. Facing a significant Medicare rate cut, the company is piloting efficiency initiatives and advocating for regulatory relief. Debt reduction, technology investment, and a strong hospice platform position the business for future growth.
Enhabit Announces Participation in Jefferies 2025 Healthcare Services Conference
DALLAS--(BUSINESS WIRE)-- #enhabit--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Jefferies 2025 Healthcare Services Confere...
Enhabit Earnings Call Transcript: Q2 2025
Q2 2025 saw year-over-year and sequential revenue and adjusted EBITDA growth, with hospice delivering strong double-digit gains and home health stabilizing Medicare census. Updated guidance reflects continued momentum, while regulatory headwinds and a CEO transition are on the horizon.
Enhabit Home Health & Hospice Announces CEO Transition Plan
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, inten...
Enhabit Reports Second Quarter 2025 Financial Results
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2025. “Our second q...
Enhabit Home Health & Hospice Announces Date of 2025 Second Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2025, on Aug....
Enhabit Transcript: Goldman Sachs 46th Annual Global Healthcare Conference
Achieved full-service provider status in 2024, driving balanced payer mix and growth in both home health and hospice. Industry trends show rising Medicare Advantage utilization and declining traditional Medicare, with operational and cost initiatives supporting margin stability.
Enhabit Announces Participation in Goldman Sachs 46th Annual Global Healthcare Conference
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conferenc...
Enhabit Earnings Call Transcript: Q1 2025
Q1 2025 delivered strong sequential growth, margin expansion, and deleveraging, with home health and hospice segments both showing robust volume and profitability gains. Cost efficiencies, improved payer mix, and strong cash flow supported a reaffirmed 2025 outlook.
Enhabit Reports First Quarter 2025 Financial Results
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. “Enhabit's fi...
Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May ...
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed t...